NeuroMetrix Income Tax Expense from 2010 to 2024

NURO Stock  USD 4.33  0.11  2.48%   
NeuroMetrix Income Tax Expense yearly trend continues to be very stable with very little volatility. Income Tax Expense is likely to drop to -2.1. During the period from 2010 to 2024, NeuroMetrix Income Tax Expense quarterly data regression pattern had sample variance of 12.2 T and median of (89,954). View All Fundamentals
 
Income Tax Expense  
First Reported
2002-12-31
Previous Quarter
-10.5 K
Current Value
5
Quarterly Volatility
751 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NeuroMetrix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NeuroMetrix main balance sheet or income statement drivers, such as Depreciation And Amortization of 52.9 K, Interest Expense of 278 K or Total Revenue of 5.6 M, as well as many exotic indicators such as Price To Sales Ratio of 0.6, Dividend Yield of 21.96 or PTB Ratio of 0.18. NeuroMetrix financial statements analysis is a perfect complement when working with NeuroMetrix Valuation or Volatility modules.
  
This module can also supplement various NeuroMetrix Technical models . Check out the analysis of NeuroMetrix Correlation against competitors.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.

Latest NeuroMetrix's Income Tax Expense Growth Pattern

Below is the plot of the Income Tax Expense of NeuroMetrix over the last few years. It is NeuroMetrix's Income Tax Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NeuroMetrix's overall financial position and show how it may be relating to other accounts over time.
Income Tax Expense10 Years Trend
Pretty Stable
   Income Tax Expense   
       Timeline  

NeuroMetrix Income Tax Expense Regression Statistics

Arithmetic Mean357,357
Geometric Mean0.00
Coefficient Of Variation977.08
Mean Deviation1,614,679
Median(89,954)
Standard Deviation3,491,651
Sample Variance12.2T
Range16.6M
R-Value0.12
Mean Square Error12.9T
R-Squared0.01
Significance0.68
Slope91,625
Total Sum of Squares170.7T

NeuroMetrix Income Tax Expense History

2024 -2.1
2023 -2.0
2022-49.4 K
2021-76.4 K
2020-90 K
2019-124 K
201812.3 M

About NeuroMetrix Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include NeuroMetrix income statement, its balance sheet, and the statement of cash flows. NeuroMetrix investors use historical funamental indicators, such as NeuroMetrix's Income Tax Expense, to determine how well the company is positioned to perform in the future. Although NeuroMetrix investors may use each financial statement separately, they are all related. The changes in NeuroMetrix's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NeuroMetrix's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on NeuroMetrix Financial Statements. Understanding these patterns can help to make the right decision on long term investment in NeuroMetrix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Income Tax Expense(2.00)(2.10)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether NeuroMetrix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NeuroMetrix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurometrix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurometrix Stock:
Check out the analysis of NeuroMetrix Correlation against competitors.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for NeuroMetrix Stock analysis

When running NeuroMetrix's price analysis, check to measure NeuroMetrix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroMetrix is operating at the current time. Most of NeuroMetrix's value examination focuses on studying past and present price action to predict the probability of NeuroMetrix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroMetrix's price. Additionally, you may evaluate how the addition of NeuroMetrix to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Commodity Directory
Find actively traded commodities issued by global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is NeuroMetrix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.27)
Revenue Per Share
5.664
Quarterly Revenue Growth
(0.29)
Return On Assets
(0.19)
Return On Equity
(0.30)
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.